{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:41:48Z","timestamp":1781149308925,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional De Promoci\u00f3n Cient\u00edfica Y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009573","name":"Universidad Nacional de Rosario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.phymed.2024.155569","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T07:05:34Z","timestamp":1711782334000},"page":"155569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Phytolacca tetramera berries extracts and its main constituents as potentiators of antifungal drugs against Candida spp."],"prefix":"10.1016","volume":"130","author":[{"given":"Estefan\u00eda","family":"Butassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Roy","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1023-1641","authenticated-orcid":false,"given":"Laura Andrea","family":"Svetaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155569_bib0001","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/jof6020066","article-title":"Encochleated amphotericin B: is the oral availability of amphotericin B finally reached?","volume":"6","author":"Aigner","year":"2020","journal-title":"J. Fungi"},{"key":"10.1016\/j.phymed.2024.155569_bib0002","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1128\/JCM.37.10.3332-3337.1999","article-title":"Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans","volume":"37","author":"Arthington-Skaggs","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.phymed.2024.155569_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152884","article-title":"The antifungal activity and mechanisms of action of quantified extracts from berries, leaves and roots of Phytolacca tetramera","volume":"60","author":"Butassi","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155569_bib0004","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2147\/IDR.S308262","article-title":"Aspirin as an antifungal-lock agent in inhibition of candidal biofilm formation in surgical catheters","volume":"14","author":"Chan","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.phymed.2024.155569_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122123","article-title":"Identification of phytolaccosides in biological samples from pokeweed intoxication patients using liquid chromatography-tandem mass spectrometry","volume":"1149","author":"Choe","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.phymed.2024.155569_bib0007","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phymed.2024.155569_bib0008","series-title":"Approved Standard-Document M27, 4 ed","article-title":"(Clinical and laboratory standards institute), 2017. Reference method for broth dilution antifungal susceptibility testing of yeasts","year":"2017"},{"key":"10.1016\/j.phymed.2024.155569_bib0009","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s15010-020-01475-8","article-title":"Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland","volume":"48","author":"Coste","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.phymed.2024.155569_bib0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jac\/dkh434","article-title":"Combinations of antifungal agents in therapy\u2013what value are they?","volume":"54","author":"Cuenca-Estrella","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phymed.2024.155569_bib0011","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/21505594.2015.1039885","article-title":"Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans","volume":"6","author":"Cui","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.phymed.2024.155569_bib0012","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1462-5822.2009.01394.x","article-title":"Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes","volume":"12","author":"Dalle","year":"2010","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.phymed.2024.155569_bib0013","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1021\/np070660i","article-title":"Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman","volume":"71","author":"Escalante","year":"2008","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phymed.2024.155569_bib0014","series-title":"Manual De T\u00e9cnicas in Vitro Para La Detecci\u00f3n De Compuestos Antifungicos","first-page":"129","article-title":"Detecci\u00f3n de antif\u00fangicos que da\u00f1an la membrana o que se unen al ergosterol","author":"Escalante","year":"2007"},{"key":"10.1016\/j.phymed.2024.155569_bib0015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/jof8101077","article-title":"Antifungal combinations against Candida species: from bench to bedside","volume":"8","author":"Fioriti","year":"2022","journal-title":"J. Fungi"},{"key":"10.1016\/j.phymed.2024.155569_bib0016","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/AAC.01162-08","article-title":"Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints","volume":"53","author":"Garcia-Effron","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phymed.2024.155569_bib0017","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","article-title":"Targeting virulence: a new paradigm for antifungals","volume":"14","author":"Gauwerky","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phymed.2024.155569_bib0018","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/cbdv.201000339","article-title":"Synthesis of novel derivatives of esculentoside A and its aglycone phytolaccagenin, and evaluation of their haemolytic activity and inhibition of lipopolysaccharide-induced nitric oxide production","volume":"8","author":"Gong","year":"2011","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.phymed.2024.155569_bib0019","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12088-017-0657-1","article-title":"Recent advances in ergosterol biosynthesis and regulation mechanisms in Saccharomyces cerevisiae","volume":"57","author":"Hu","year":"2017","journal-title":"Indian J. Microbiol."},{"key":"10.1016\/j.phymed.2024.155569_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: the silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb. Cell"},{"key":"10.1016\/j.phymed.2024.155569_bib0021","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/jof9100955","article-title":"Biofilm Formation in medically important Candida species","volume":"9","author":"Malinovsk\u00e1","year":"2023","journal-title":"J. Fungi"},{"key":"10.1016\/j.phymed.2024.155569_bib0022","first-page":"135","article-title":"Fundamental concepts of azole compounds and triazole antifungals: a beginner's review","volume":"37","author":"Mart\u00ednez-Mat\u00edas","year":"2018","journal-title":"P. R. Health Sci. J."},{"key":"10.1016\/j.phymed.2024.155569_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1227837","article-title":"Synergistic therapy for invasive fungal infection","volume":"13","author":"Menghani","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.phymed.2024.155569_bib0024","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.mib.2006.06.007","article-title":"Candida albicans biofilm development, modeling a host\u2013pathogen interaction","volume":"9","author":"Nett","year":"2006","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.phymed.2024.155569_bib0025","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phymed.2024.155569_bib0026","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phymed.2024.155569_bib0027","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1517\/17460441.2013.807245","article-title":"Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs","volume":"8","author":"Pierce","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.phymed.2024.155569_bib0028","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1016\/j.bmc.2008.07.042","article-title":"Antifungal activity of synthetic di (hetero) arylamines based on the benzo [b] thiophene moiety","volume":"16","author":"Pinto","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phymed.2024.155569_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113777","article-title":"Metabolic exploration of the developmental abnormalities and neurotoxicity of Esculentoside B, the main toxic factor in Phytolaccae radix","volume":"176","author":"Ren","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2024.155569_bib0030","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1099\/jmm.0.075291-0","article-title":"New pharmacological properties of medicago sativa and Saponaria officinalis saponin-rich fractions addressed to Candida albicans","volume":"63","author":"Sadowska","year":"2014","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.phymed.2024.155569_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-015-0522-x","article-title":"Effect of the crude extract of Eugenia uniflora in morphogenesis and secretion of hydrolytic enzymes in Candida albicans from the oral cavity of kidney transplant recipients","volume":"15","author":"Silva-Rocha","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.phymed.2024.155569_bib0032","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.phymed.2024.155569_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phymed.2024.155569_bib0034","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.mycmed.2019.100907","article-title":"Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina","volume":"29","author":"Vigezzi","year":"2019","journal-title":"J. Mycol. Med."},{"key":"10.1016\/j.phymed.2024.155569_bib35","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324002344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324002344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T03:02:52Z","timestamp":1718161372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"alternative-id":["S0944711324002344"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155569","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phytolacca tetramera berries extracts and its main constituents as potentiators of antifungal drugs against Candida spp.","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155569"}}